Adtalem Global Education (NYSE:CVSA) SVP Douglas Beck Sells 2,650 Shares

Adtalem Global Education Inc. (NYSE:CVSA) SVP Douglas Beck sold 2,650 shares of the stock in a transaction on Tuesday, July 7th. The shares were sold at an average price of $135.40, for a total transaction of $358,810.00. Following the transaction, the senior vice president owned 35,509 shares in the company, valued at $4,807,918.60. This trade represents a 6.94% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Adtalem Global Education Stock Performance

CVSA opened at $131.17 on Friday. The business has a 50-day moving average of $124.40. The company has a market cap of $4.46 billion, a P/E ratio of 20.43, a P/E/G ratio of 0.99 and a beta of 0.62. Adtalem Global Education Inc. has a 1-year low of $86.97 and a 1-year high of $156.26. The company has a debt-to-equity ratio of 0.36, a current ratio of 0.70 and a quick ratio of 0.70.

Adtalem Global Education (NYSE:CVSA) last issued its quarterly earnings results on Thursday, May 7th. The company reported $1.98 EPS for the quarter, topping the consensus estimate of $1.73 by $0.25. The business had revenue of $487.03 million for the quarter. Adtalem Global Education had a net margin of 12.26% and a return on equity of 20.19%. The business’s revenue for the quarter was up 4.5% on a year-over-year basis. During the same period in the previous year, the business posted $1.92 EPS. Adtalem Global Education has set its FY 2026 guidance at 7.950-8.150 EPS. As a group, sell-side analysts expect that Adtalem Global Education Inc. will post 8.04 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of research analysts have commented on CVSA shares. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Adtalem Global Education in a report on Friday, May 22nd. Zacks Research lowered Adtalem Global Education from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, March 25th. Barrington Research restated an “outperform” rating and set a $170.00 price objective on shares of Adtalem Global Education in a research note on Monday, June 8th. Truist Financial lifted their price objective on shares of Adtalem Global Education from $130.00 to $140.00 and gave the stock a “buy” rating in a report on Monday, May 11th. Finally, Wall Street Zen upgraded shares of Adtalem Global Education from a “hold” rating to a “buy” rating in a research note on Saturday, June 13th. Two analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $155.00.

Adtalem Global Education Company Profile

Adtalem Global Education (NYSE: CVSA) is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.

Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.